Bio Briefs
Posted By
Recent Posts on This Topic | See All >
-
Feb 07, 2012 Support grows for medical-device community -
Dec 19, 2011 BioAccel launches network to attract bio funding
-
Jul 19, 2011 Cardinal Health opens $11M Phoenix facility
-
Apr 07, 2011 Algae Biosciences Corp. taken public
Share on Twitter
Share on Facebook
Email to a friend
Print Article
InNexus primate study clears way for human trials on non-Hodgkins lymphoma tumors
[Source: Phoenix Business Journal - by Angela Gonzales] - InNexus Biotechnology Inc. has completed a primate study it says confirms the effectinvess and safety of its treatment for non-Hodgkins lymphoma tumors.
The Toronto, Canadian company (TSX:IXS.V), whose business offices are based in Scottsdale, also scheduled a meeting with the U.S. Food and Drug Administration to discuss the design of a clinical study on humans.
For more information click here.
Quick Links
- NEW: About the Arizona Center for Civic Leadership
- Arizona Biosciences News
- Arizona BioMap
- Roadmap Progress Updates
- Reports & Multimedia
- Timeline: Arizona's Bio Growth
- Arizona Bio Orgs on Twitter
- Arizona BioBasics
- The Biozona Brand
- Newsletter Signup
Download a new brochure from the Flinn Foundation outlining the 2011 progress on Arizona's Bioscienced Roadmap: a record high in bioscience jobs, plus gains in firms and venture-capital funding. Numerous achievements during the year advanced the core strategies of the Roadmap.
Also, read the full Performance Assessment describing in detail Arizona's 2011 progress on key Roadmap metrics.
